POSTS TAGGED AS Vertex Pharmaceuticals

Clinical Success for Gene Editing, but at a Price None Could Afford

The first gene-editing treatment for Sickle Cell
“Many CRISPR treatments are in trials, but in 2022, Vertex Pharmaceuticals, based in Boston, [MORE]

Gene Editing Shows Long Term Efficacy forBeta Thalassemia and Sickle Cell Disease

Sickle Cell Anemia
“In a late-breaking abstract presented at the European Hematology Association (EHA) Congress, a group of researchers that includes [MORE]

Experimental Cell Therapy Thought to Cure T1 Diabetes for the First Time

Potential cure for T1 diabetes using stem cells
“In a Vertex Pharmaceuticals clinical trial, an experimental treatment may have cured type [MORE]